AstraZeneca gets FDA breakthrough therapy label for asthma treatment
The drug, tezepelumab, is an injectable treatment that is expected to help a wider range of patients than existing asthma…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Strides Pharma’s promoter sells stake worth ₹20 cr
According to the block deal data available with the NSE, Abusha offloaded 4 lakh shares, amounting to 0.45 per cent stake in the…
Lupin to train over 1,000 graduates for pharma industry
Mumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost INR 20 crore on this programme
Liver disease drug could help restore cells damaged by Alzheimer’s
New study found ursodeoxycholic acid (UDCA) improves mitochondrial dysfunction – which is known to be a causative factor for both…
Pall Corporation, Celltheon enter into partnership for biotherapeutics development
This is a part of Pall’s strategic approach to forming key partnerships that help enable better, safer and faster biologic…
Drugmaker GSK to eliminate 650 US jobs
The savings from these cuts will help fund increases in research and development and commercial support of new products, Rhyne…
Aurobindo to acquire dermatology and oral solids businesses from Sandoz
The acquisition is in line with Aurobindo's strategy to grow and diversify our business in the US
ProQR drug for rare childhood blindness succeeds in early trial
The early trial tested the RNA-based drug, QR-110, in 10 patients with a certain genetic mutation that resulted in an eye disorder…
Strides receives USFDA approval for Potassium Chloride Extended Release tablets
The product will be launched immediately by Strides Pharma in the US markets
Zydus Cadila gets USFDA nod for herpes viruses treatment drug
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Acyclovir Sodium…